The pressroom · what fregime is
fregime compiles the day's reporting on your stocks, counts the publishers behind every claim, and grades your assumptions against the record.
Just cited facts, no charts to distract. We press no opinion, as we value yours.
Scroll: how one development becomes a line in the record
independent publishers
The most corroborated development on the record, live. The count is per claim and unbounded: as many credible publishers as report it.
The record only grows. Every development lands with its date and its receipts, and stays put. When a correction arrives, it is stamped onto the record beside the original line. Nothing is quietly rewritten.
10 publishers
8 publishers
Maruti Suzuki India commissioned a 300 kW Green Hydrogen electrolyser plant at its Manesar facility.
7 publishers
7 publishers
Write what you believe about a stock's fundamentals in your own words. Each morning, fregime reads the day's cited record against it and shows where the reporting supports you and where it argues back. Fundamentals, not chart patterns: the grade comes from reported facts.
“No corroborated developments touch Maruti Suzuki India this week.”
by 18 cited reports this week
A sample assumption, graded against the cited record the way the thesis desk grades yours: write what you believe, and every morning's evidence lands on it, supported, challenged, or untouched, with citations.
Part of the desk · preview is waitlist-gated
What an opinion column would say here is struck before it is set.
Every sentence on this site reports what happened, with its source attached. We compile and cite; we do not opine.
Before market open on trading days, the counted record is composed into a numbered edition: the day's most corroborated developments, every claim carrying its receipts.
The Insurance Regulatory and Development Authority of India proposed sweeping changes to insurance distribution, commissions, and expense structures. PB Fintech shares declined following the proposal, with insurance stocks experiencing heavy selling as the regulatory changes affect how insurers and distributors earn from policies.
The US government has exempted certain specialty pharmaceutical products and associated ingredients imported from India and 19 other countries from a 100% tariff. The exemption applies to drugs and ingredients used to treat rare medical conditions.
Closes are the exchange's published end-of-day figures for their dated trading day. Evidence last checked 2 Oct 2026, 11:59 IST.
We aggregate reporting from credible sources with receipts, and count the independent publishers behind every claim. Single-source reports are labeled. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.